Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01071707 · ClinicalTrials.gov registry record
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 108
- Enrollment target
NCT01071707 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 108 participants.
The verdict
NCT01071707 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
Study purpose: The disease course of idiopathic pulmonary fibrosis (IPF) is variable. During the course of the disease some patients will get better, some will stay the same, and others will get worse. Currently doctors do not have any way to predict an individual patients disease course. The purpose of this study is to determine if 'biomarkers' such as proteins or genes isolated at the time of diagnosis can be used to predict the disease course. These 'biomarkers' will be obtained from samples of blood, from a procedure call a bronchoscopy, and in some patients from extra tissue obtained by a surgical lung biopsy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01071707
The ClinicalTrials.gov registry entry for NCT01071707 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01071707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01071707 about?
NCT01071707 is a clinical study titled "Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)". Study purpose: The disease course of idiopathic pulmonary fibrosis (IPF) is variable. During the course of the disease some patients will get better, some will stay the same, and others will get worse. Currently doctors do not have any way to predict an individual patients disease course. The purpo...
What is the current status of trial NCT01071707?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2009-12. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT01071707?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.